Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Schou, Mogens
1989.
Vol. 13,
Issue. ,
p.
17.
Ebadi, M.
Pfeiffer, R.F.
and
Murrin, L.C.
1990.
Pathogenesis and treatment of neuroleptic malignant syndrome.
General Pharmacology: The Vascular System,
Vol. 21,
Issue. 4,
p.
367.
McLean, Donald R.
Hafez, Mohammed S.
Duarte-Afara, Ramon R.
and
Obeid, Mohamed E.H.
1992.
Four Cases of Neuroleptic Malignant Syndrome.
Annals of Saudi Medicine,
Vol. 12,
Issue. 1,
p.
24.
Dursun, SerdarM.
Mathew, V.Mathew
and
Reveley, MichaelA.
1993.
Toxic serotonin syndrome after fluoxetine plus carbamazepine.
The Lancet,
Vol. 342,
Issue. 8868,
p.
442.
Groleau, Georgina
1994.
Lithium Toxicity.
Emergency Medicine Clinics of North America,
Vol. 12,
Issue. 2,
p.
511.
Lev, Roneet
and
Clark, Richard F.
1994.
Neuroleptic malignant syndrome presenting without fever: Case report and review of the literature.
The Journal of Emergency Medicine,
Vol. 12,
Issue. 1,
p.
49.
Prager, Laura M.
Millham, Frederick H.
and
Theodore, Stern A.
1994.
Neuroleptic Malignant Syndrome: A Review for Intensivists.
Journal of Intensive Care Medicine,
Vol. 9,
Issue. 5,
p.
227.
Theoharides, Theoharis C.
Harris, R. Scott
and
Weckstein, Douglas
1995.
Neuroleptic Malignant-Like Syndrome due to Cyclobenzaprine?.
Journal of Clinical Psychopharmacology,
Vol. 15,
Issue. 1,
p.
79.
Laier, Gro
1996.
The serotonin syndrome: Definition and eause.
Nordic Journal of Psychiatry,
Vol. 50,
Issue. 3,
p.
249.
Nijhawan, Pardeep K.
Katz, Gail
and
Winter, Stephen
1996.
Psychiatric illness and the serotonin syndrome.
Critical Care Medicine,
Vol. 24,
Issue. 6,
p.
1086.
Cuesta, MJ
Perez-Nievas, F
Hernandez, R
Lanzas, G
and
Peralta, V
1996.
Neuroleptic malignant syndrome following a lithium-induced nephrogenic diabetes insipidus.
European Psychiatry,
Vol. 11,
Issue. 6,
p.
325.
Robert, P
Senard, JM
Fabre, M
Cabot, C
and
Cathala, B
1996.
Syndrome sérotoninergique lors d'une intoxication aiguë aux antidépresseurs.
Annales Françaises d'Anesthésie et de Réanimation,
Vol. 15,
Issue. 5,
p.
663.
John, Leela
Perreault, Marc M
Tao, Tina
and
Blew, Philip G
1997.
Serotonin Syndrome Associated With Nefazodone and Paroxetine.
Annals of Emergency Medicine,
Vol. 29,
Issue. 2,
p.
287.
BUTZKUEVEN, H.
1997.
A case of serotonin syndrome induced by moclobemide during an extreme heatwave.
Australian and New Zealand Journal of Medicine,
Vol. 27,
Issue. 5,
p.
603.
Petzinger, Giselle M.
and
Bressman, Susan B.
1997.
A case of tetrabenazine‐induced neuroleptic malignant syndrome after prolonged treatment.
Movement Disorders,
Vol. 12,
Issue. 2,
p.
246.
Bertorini, Tulio E.
1997.
MYOGLOBINURIA, MALIGNANT HYPERTHERMIA, NEUROLEPTIC MALIGNANT SYNDROME AND SEROTONIN SYNDROME.
Neurologic Clinics,
Vol. 15,
Issue. 3,
p.
649.
Mills, Kirk C.
1997.
SEROTONIN SYNDROME.
Critical Care Clinics,
Vol. 13,
Issue. 4,
p.
763.
Keltner, Norman L
1997.
Catastrophic Consequences Secondary to Psychotropic Drugs, Part 1.
Journal of Psychosocial Nursing and Mental Health Services,
Vol. 35,
Issue. 4,
p.
41.
Fricchione, Gregory
Bush, George
Fozdar, Manish
Francis, Andrew
and
Fink, Max
1997.
Recognition and Treatment of the Catatonic Syndrome.
Journal of Intensive Care Medicine,
Vol. 12,
Issue. 3,
p.
135.
GROUNDS, D.
1997.
Grounds for more backup.
Australian and New Zealand Journal of Medicine,
Vol. 27,
Issue. 5,
p.
602.
eLetters
No eLetters have been published for this article.